Aa
A
A
Close
Avatar universal
delta 32 infusion trials where to go for information on this topic
information on delta 32 infusion treatment provided by the science chanel
Cancel
3 Answers
Page 1 of 1
Avatar universal
Eligibility

Ages Eligible for Study:  

18 Years and older

Genders Eligible for Study:  

Both

Accepts Healthy Volunteers:  

No

Criteria

Inclusion Criteria:
•Documented HIV infection prior to study entry
•Must be willing to comply with study-mandated evaluations; including not changing their antiretroviral regimen (unless medically indicated) during the study period.

Cohort 1, 2 and 3 (Enrollment Completed)

Cohort 5:
•Must have received HAART therapy, and had undetectable viral loads for at least 1 year.
•HIV-1 RNA 350 cells/mm3
•Heterozygous for the CCR5 delta-32 mutation
•On stable antiretroviral medication (no changes to treatment within 4 weeks of screening and willing to discontinue current antiretroviral therapy during the structured therapy interruption

Cohort 4
•On stable antiretroviral medication (no changes to treatment within 4 weeks of screening and willing to continue on current antiretroviral therapy through week 8 after infusion
•CD4+ T cell count >350 cells/mm3.
•HIV-1 >1,000 copies/mL at screen and not responding to current antiviral therapy (i.e. HIV-RNA plasma levels > 1000 copies/ml after at least 12 weeks of stable, unchanged ARV therapy).

Estimated Study Completion Date: December 2013
Comment
Cancel
Comment
Avatar universal
Comment
Comment
Submit Comment
Avatar universal
thank you very much for information
Comment
Cancel
Comment
Avatar universal
Comment
Comment
Submit Comment
Your Answer
Avatar universal
Answer
Know how to answer? Tap here to leave your answer...
Answer
Submit Answer
A
A
Blank
Weight Tracker
Weight Tracker
Start Tracking Now
HIV, Living With Community Resources